153 related articles for article (PubMed ID: 25997988)
1. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations.
Hong W; Abi-Raad R; Alomari AK; Hui P; Buza N
Hum Pathol; 2015 Jul; 46(7):1000-5. PubMed ID: 25997988
[TBL] [Abstract][Full Text] [Related]
2. Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis.
Abi-Raad R; Alomari A; Hui P; Buza N
Int J Gynecol Pathol; 2014 Sep; 33(5):524-30. PubMed ID: 25083971
[TBL] [Abstract][Full Text] [Related]
3. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940
[TBL] [Abstract][Full Text] [Related]
5. KRAS Mutations in Mucinous Lesions of the Uterus.
He M; Jackson CL; Gubrod RB; Breese V; Steinhoff M; Lawrence WD; Xiong J
Am J Clin Pathol; 2015 Jun; 143(6):778-84. PubMed ID: 25972319
[TBL] [Abstract][Full Text] [Related]
6. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
Aoun BA; Skala SL
Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
[TBL] [Abstract][Full Text] [Related]
7. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium.
Alomari A; Abi-Raad R; Buza N; Hui P
Mod Pathol; 2014 May; 27(5):675-80. PubMed ID: 24186144
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
Chekmareva M; Ellenson LH; Pirog EC
Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology and immunohistochemical features in endometrial adenocarcinoma simulating microglandular hyperplasia. A case report.
Shidham VB; Dayer AM; Basir Z; Kajdacsy-Balla A
Acta Cytol; 2000; 44(4):661-6. PubMed ID: 10934963
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.
Xiong J; He M; Hansen K; Jackson CL; Breese V; Quddus MR; Sung CJ; Lomme MM; Lawrence WD
Gynecol Oncol; 2016 Jul; 142(1):163-168. PubMed ID: 27154241
[TBL] [Abstract][Full Text] [Related]
11. Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix.
Fukunaga M
Pathol Int; 2000 Jul; 50(7):541-5. PubMed ID: 10886736
[TBL] [Abstract][Full Text] [Related]
12. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium.
Qiu W; Mittal K
Int J Gynecol Pathol; 2003 Jul; 22(3):261-5. PubMed ID: 12819393
[TBL] [Abstract][Full Text] [Related]
13. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
14. Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix.
Zaloudek C; Hayashi GM; Ryan IP; Powell CB; Miller TR
Int J Gynecol Pathol; 1997 Jan; 16(1):52-9. PubMed ID: 8986533
[TBL] [Abstract][Full Text] [Related]
15. KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion.
Stewart CJ; Amanuel B; Grieu F; Carrello A; Iacopetta B
J Clin Pathol; 2010 Jul; 63(7):604-8. PubMed ID: 20591910
[TBL] [Abstract][Full Text] [Related]
16. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
17. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
Zheng XZ; Zhan Y; Ma JH; Xu HW; Zhi WX; Chen TB; Qin XY; Wang P; Zhang LH; Gu YC; Jin YL; Zhu L; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):687-690. PubMed ID: 30220122
[No Abstract] [Full Text] [Related]
18. Microglandular adenocarcinoma of the uterus mimicking microglandular cervical hyperplasia.
Zamecnik M; Skalova A; Opatrny V
Ann Diagn Pathol; 2003 Jun; 7(3):180-6. PubMed ID: 12808571
[TBL] [Abstract][Full Text] [Related]
19. A case of microglandular adenocarcinoma of the endometrium.
Karateke A; Haliloglu B; Atay V; Gurbuz A; Kir G
Gynecol Oncol; 2005 Dec; 99(3):778-81. PubMed ID: 16229880
[TBL] [Abstract][Full Text] [Related]
20. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
